EIP Pharma fetches $20.5 mln Series B
Cambridge, Massachusetts-based EIP Pharma, a therapeutics company focused on CNS diseases, has closed $20.5 million in Series B financing. The lead investor was Access Industries.
16 May 2018•1 min read
Cambridge, Massachusetts-based EIP Pharma, a therapeutics company focused on CNS diseases, has closed $20.5 million in Series B financing. The lead investor was Access Industries.
